新闻Zondler leaves Biotheranostics, Inc. as CIO.Zondler joins Veracyte from Biotheranostics, part of Hologic, where he served as CIO.
新闻Biotheranostics, Inc. launched CancerTYPE ID test on Jan 1st '10.Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers.
新闻Biotheranostics, Inc. launches Not Another Minute campaign.Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for early-stage, hormone receptor-positive (HR+) breast cancer patients.
